Effects of monatepil maleate, a new Ca2+ channel antagonist with α1-adrenoceptor antagonistic activity, on cholesterol absorption and catabolism in high cholesterol diet-fed rabbits

Japanese Journal of Pharmacology

Volumn 78, Issue 3, 1998, Pages 303-312

  Ikeno, Akihisa ^a   Sumiya, Toshiki ^a   Minato, Hisao ^a   Fujitani, Buichi ^a   Masuda, Yoshinobu ^a   Hosoki, Kanoo ^a   Kurono, Masuo ^a   Yasuba, Masashi ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Cholesterol absorption; Cholesterol catabolism; Low density lipoprotein receptor; Monatepil maleate

Indexed keywords

BILE ACID; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MONATEPIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY EXCRETION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL METABOLISM; CONTROLLED STUDY; GASTROINTESTINAL ABSORPTION; HYPERLIPIDEMIA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT;

EID: 0031730582     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.78.303     Document Type: Article

References (39)

1. Helgeland A: Treatment of mild hypertension: a five year controlled drug trial. Am J Med 69, 725-732 (1980)
2. Wilson PW: Established risk factors and coronary artery disease: the Framingham study. Am J Hypertens 7, 7S-12S (1994)
3. Nakamura H: Effects of antihypertensive drugs on plasma lipids. Am J Cardiol 60, 24E-28E (1987)
4. Leren P: Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties. Am J Med 82, Suppl IA, 31-35 (1987)
5. Cubeddu LX, Pool JL, Bloomfield R, Klotman PE, Pickering BI, Wombolt DG, Nelson EB and Halperin A: Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension. Am J Hypertens 1, 158-167 (1988)
6. Monmany J, Benet T, Gómez JA, Domingo P and Roca-Cusachs A: Effects on lipids of antihypertensive treatment with doxazosin compared to atenolol (abst). Am J Hypertens 4, 24A (1991)
7. Waters D, Lespérance J, Francetich M, Causey D, Théroux P, Chiang Y-K, Hudon G, Lemarbre L, Reitman M, Joyal M, Gosselin G, Dyrda I, Macer J and Havel RJ: A controlled clinical trial to assess the effects of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 82, 1940-1953 (1990)
8. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S and Deckers JW: Retardation of angiographic progression of coronary artery disease by nifedipine: Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Lancet 335, 1109-1113 (1990)
9. 2+ entry blocker, AJ-2615, in vitro. J Cardiovasc Pharmacol 22, 804-809 (1993)
10. 1-adrenergic blocking activity in experimental hypertensive animals. J Cardiovasc Pharmacol 21, 815-821 (1993)
11. Minato H, Ikeno A, Yamada T, Kato H, Zushi K, Kurokawa M, Masuda Y, Hosoki K and Karasawa T: Inhibitory effect of the new calcium antagonist AJ-2615 on progression of atherosclerosis in cholesterol-fed rabbits. J Cardiovasc Pharmacol 21, 663-669 (1993)
12. 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese macaca fuscate monkeys. Arzneimittelforschung 44, 288-297 (1994)
13. 1-adrenergic-blocking activity and nitrendipine on lipoprotein and carbohydrate metabolism in patients with hypertension. Am J Hypertens 7, 161S-166S (1994)
14. Schneider WJ, Brown MS and Goldstein JL: Kinetic defects in the processing of the low density lipoprotein receptor in fibroblasts from WHHL rabbits and a family with familial hypercholesterolemia. Mol Biol Med 1, 353-367 (1983)
15. Shimada Y, Tanzawa K, Kuroda M, Tsujita Y, Arai M and Watanabe Y: Biochemical characterization of skin fibroblasts derived from WHHL-rabbit, a notable animal model for familial hypercholesterolemia. Eur J Biochem 118, 557-564 (1981)
16. Shiomi M, Ito T and Watanabe Y: Increase in hepatic low-density lipoprotein receptor activity during pregnancy in Watanabe heritable hyperlipidemic rabbits; an animal model for familial hypercholesterolemia. Biochim Biophys Acta 917, 92-100 (1987)
17. Tanzawa K, Shimada Y, Kuroda M, Tsujita Y, Arai M and Watanabe Y: WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett 118, 81-84 (1980)
18. Amorosa LF, Rozovski SJ, Ananthakrishnan R, Coly E, Alhinai A, Martucci C, Schneider SH, Shimamura T and Khachadurian AK: Effects of pravastatin on cholesterol metabolism in Watanabe heritable hyperlipidemic rabbits. Jpn Heart J 33, 451-463 (1992)
19. Miettinen TA, Ahrens EH and Grundy SM: Quantitative isolation and gas-liquid chromatographic analysis of total dietary and fecal neutral steroids. J Lipid Res 6, 411-424 (1965)
20. Schwarz CC, Halloran LG, Vlahcevic ZR, Gregory DH and Swell L: Preferential utilization of free cholesterol from high-density lipoproteins for biliary secretion in man. Science 7, 62-64 (1978)
21. Hidaka H, Nakamura T, Aoki T, Kojima H, Nakajima Y, Kosugi K, Hatanaka I, Harada M, Kobayashi M, Tanura A, Fujii T and Shigeta Y: Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis. J Lipid Res 31, 881-888 (1990)
22. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275 (1951)
23. Imai Y, Kawata S, Inada M, Miyoshi S, Minami Y, Matsuzawa Y, Uchida K and Tarui S: Effect of cholestyramine on bile acid metabolism in conventional rats. Lipids 22, 513-516 (1987)
24. Kurono M, Yoshida K, Arakawa S and Naruto S: Determination of a novel calcium entry blocker, AJ-2615, in plasma using solid-phase extraction and high-performance liquid chromatography with electrochemical detection. J Chromatogr 532, 175-180 (1990)
25. Folch J, Lees M and Stanley GHS: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226, 497-509 (1957)
26. Allain CC, Poon LS, Chan CSG, Richmond W and Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20, 470-475 (1974)
27. Burstein M, Scholnick HR and Morfin R: Rapid method for the isolation of lipoproteins from human serum by precipitaion with polyanions. J Lipid Res 11, 583-595 (1970)
28. Fried R and Hoeflmayr J: Eine einfache indirekte Bestimmungsmethode der β-Lipoproteide. Klin Wochenschr 41, 246 (1963) (in German)
29. Mashige F, Tanaka N, Maki A, Kamei S and Yamanaka M: Direct spectrophotometry of total bile acids in serum. Clin Chem 27, 1352-1356 (1981)
30. Richmond W: Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19, 1350-1356 (1973)
31. Spayd RW, Bruschi B, Burdick BA, Dappen GM, Eikenberry JN, Esders TW, Figueras J, Goodhue CT, LaRossa DD, Nelson RW, Rand RN and Wu T-W: Multilayer film elements for clinical analysis: applications to representative chemical determinations. Clin Chem 24, 1343-1350 (1978)
32. Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15, 212-216 (1976)
33. Notake M, Kondo Y, Nomura H, Nakano K, Hosoki K and Miyazaki M: Up-regulation of hepatic LDL receptor gene expression by monatepil, a novel calcium antagonist, in high cholesterol diet-fed Japanese monkeys. Am J Hypertens 7, 1026-1030 (1994)
34. Brown MS and Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-37 (1986)
35. Slater HR, Shepherd J and Packard CJ: Receptor-mediated catabolism and tissue uptake of human low density lipoprotein in the cholesterol-fed, atherosclerotic rabbit. Biochim Biophys Acta 713, 435-445 (1982)
36. D'Eletto RD and Javitt NB: Effect of doxazosin on cholesterol synthesis in cell culture. J Cardiovasc Pharmacol 13, Suppl 2, S1-S4 (1989)
37. 1-antagonist, doxazosin, on hepatic lipid levels and metabolism in the golden hamster. J Cardiovasc Pharmacol 18, 354-360 (1991)
38. Sumiya T, Ikeno A, Kato H, Fujitani B, Masuda Y, Hosoki K and Miyazaki M: Effect of monatepil (AJ-2615) on acyl CoA: cholesterol acyltransferase (ACAT) activity in the liver of cholesterol-fed monkeys. Am J Hypertens 10, 779-785 (1997)
39. Suckling KE and Stange EF: Role of acyl CoA:cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res 26, 647-674 (1985)